THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN™

Information for Authors

Call for Papers


American Health & Drug Benefits offers an open forum for all healthcare stakeholders to exchange ideas and present their needs, data, innovations, and initiatives to facilitate patient-centered healthcare and benefit design models that meet the needs of all stakeholders—Distributors, Employers, Evaluators, Manufacturers, Patients, Payers, Providers, Purchasers, Regulators, and Researchers.

Readers are invited to submit articles that aim at improving the quality of patient care and the US healthcare delivery system in general and of benefit design strategies in particular. All articles will undergo a blind peer review, and acceptance is based on that review.

Areas of high interest include:
• Adherence Issues
• Benefit Design
• Comparative Effectiveness Analyses
• Cost-Effectiveness Analyses
• Decision-Making Tools
• Healthcare Trends
• Health Economics
• Health Plan Initiatives/Innovation
• Health Information Technology
• Innovation in Patient Care
• Off-label Use/Misuse
• Original Research
• Pharmacoeconomics
• Reimbursement Strategies
• Wellness Programs

Clinical topics of interest include:
AGING/DEMENTIA-With the aging of the US population, there is a growing need for early implementation of outcome-based preventive and therapeutic strategies for older people.

ALLERGIES-Allergies, such as allergic or seasonal rhinitis, affect millions of Americans daily, resulting in a significant economic burden and human cost. Under treatment and lack of adherence are common obstacles to patient management.

ARTHRITIS-Musculoskeletal conditions, such as rheumatoid arthritis or osteoporosis, are on the increase, yet many patients are undiagnosed and untreated. Comparing new and available therapies is a key target for improving patient outcomes and reducing costs.

CANCER CARE-The growing focus on biologic agents dictates an enhanced study of these therapeutic options, including reimbursement policies, costmanagement, industry trends, and the biologic pipeline updates.

CARDIOVASCULAR DISEASE-Still a leading cause of morbidity and mortality among men and women. Original, outcome-based research on appropriate therapies, cost-comparisons, emerging prevention strategies, and comparative effectiveness of best practices will enhance readers' decision-making.

DIABETES, OBESITY-The increasing comorbid epidemics of these twin conditions mandates a thorough examination of best therapies, adherence issues, access, and prevention strategies. We invite articles that will address how to improve patient outcomes and best individualized patient care.

GASTROINTESTINAL CONDITIONS-Recognizing GI conditions, such as hepatitis C, Crohn's disease, or inflammatory bowel disorder, remains a challenge.

INFECTIOUS DISEASES-The spread of common and emerging pathogens within the hospital and in the community remains a major concern requiring increased vigilance.

MENTAL DISORDERS-Depression, bipolar disorder, and schizophrenia exert a huge financial and human burden on individuals, employers, and payers. Topics of interest include comparative effectiveness analyses, best practices, and reimbursement.

PAIN MANAGEMENT-Chronic pain is associated with a slew of complicated medical disorders and an enormous economic burden, yet pain medications are still underused. Appropriate topics include best therapies, diagnosis, and clinicians' anxiety about addiction issues and potential misuse.

Please submit manuscripts electronically to editorial@AHDBonline.com, or call 732-992-1892.


E-mail address
Advertisement